A Silent Condition with Growing Impact Liver disease linked to metabolic dysfunction is no longer a niche concern. It is increasingly recognised as one of the most common chronic conditions worldwide, yet it remains underdiagnosed and often overlooked in routine care. A key reason for this is its silent nature. In its early stages, excess […]
This project is supported by the Innovative Health Initiative Joint Undertaking (IHI JU) under grant agreement No 101132946. The JU receives support from the European Union’s Horizon Europe research and innovation programme and COCIR, Efpia, EuropaBio, MedTech Europe, Vaccines Europe and Mercodia Aktiebolag, Metadeq Limited and Julius Clinical Research BV.
Funded by the European Union, the private members, and those contributing partners of the IHI JU. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the aforementioned parties. Neither of the aforementioned parties can be held responsible for them.
Privacy policy Cookie statement
